Abstract
Evidence-based medicine has provided the foundation for refinement of the guideline development process and the emergence of the disciplines of measuring quality, performance, and outcomes. With implementation of electronic medical records as part of healthcare reform, multiple aspects of these disciplines will be incorporated into clinical cardiac electrophysiology. Performance measures and quality metrics will assume an influential role in the management of patients with heart rhythm disturbances in the near future.
Similar content being viewed by others
References
Spertus, J. A., Eagle, K. A., Krumholz, H. M., et al. (2005). American College of Cardiology/American Heart Association Task Force on Performance Measures. American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. Journal of the American College of Cardiology, 45, 1147–56.
Bonow, R. O., Masoudi, F. A., Rumsfeld, J. S., Delong, E., Estes, N. A., 3rd, Goff, D. C., Jr., et al. (2008). ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. American College of Cardiology/American Heart Association Task Force on Performance Measures. Circulation, 118(24), 2662–6.
Estes, N. A., 3rd, Halperin, J. L., Calkins, H., Ezekowitz, M. D., Gitman, P., Go, A. S., et al. (2008). ACC/AHA/Physician Consortium 2008 Clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation). Developed in collaboration with the Heart Rhythm Society. American College of Cardiology; American Heart Association Task Force on Performance Measures; Physician Consortium for Performance Improvement. Journal of the American College of Cardiology, 51(8), 84.
Califf, R. M., Peterson, E. D., Gibbons, R. J., Garson, A., Jr., Brindis, R. G., Beller, G. A., et al. (2002). Integrating quality into the cycle of therapeutic development. Journal of the American College of Cardiology, 40(11), 1895–901.
Califf, R. (2008). The benefits of moving quality to a national level. American Heart Journal, 156(6), 1019–22.
Committee on Quality of Health Care in America, Institute of Medicine. (1999). To err is human: building a safer health system. Washington, DC: The National Acadamies Press.
Committee on Quality of Health Care in America, Institute of Medicine. (2001). Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press.
Institute of Medicine of the National Academies. (2006). Pathways to quality health care. Rewarding provider performance, aligning incentives in medicare. Committee on Redesigning Health Insurance Performance Measures, Payment, and Performance Improvement Programs, Board on Health Care Services I.. Washington D.C.: The National Acadamies Press.
Stead, W. W., Kelly, B. J., & Kolodner, R. M. (2005). Achievable steps toward building a National Health Information infrastructure in the United States. Journal of the American Medical Informatics Association, 12(2), 113–20.
Glickman, S. W., Schulman, K. A., Peterson, E. D., Hocker, M. B., Cairns, C. B., Stead, W. W., et al. (2008). Evidence-based perspectives on pay for performance and quality of patient care and outcomes in emergency medicine. Annals of Emergency Medicine, 51(5), 622–31.
Glickman, S. W., Ou, F. S., DeLong, E. R., Roe, M. T., Lytle, B. L., Mulgund, J., et al. (2007). Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA, 297(21), 2373–80.
Hlatky, M. A., Sanders, G. D., & Owens, D. K. (2005). Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator. Health Aff (Millwood), 24(1), 42–51.
Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A., 3rd, Freedman, R. A., Gettes, L. S., et al. (2008). Circulation, 117(21), e350–408.
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., et al. (1996). Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial investigators. The New England Journal of Medicine, 335, 1933–40.
Moss, A. J., Zareba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. The New England Journal of Medicine, 346, 877–83.
Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., Hafley, G., et al. (1999). A randomized study of the prevention of sudden death in patients with coronary artery disease: Multicenter Unsustained Tachycardia Trial (MUSTT). The New England Journal of Medicine, 341, 1882–90.
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., et al. (2005). Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. The New England Journal of Medicine, 352, 225–37.
Kadish, A., Dyer, A., Daubert, J. P., et al. (2004). Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. The New England Journal of Medicine, 350, 2151–8.
Ottervanger, J. P., Ramdat Misier, A. R., Dambrink, J. H., De Boer, M. J., Hoorntje, J. C., Gosselink, A. T., et al. (2007). Mortality in patients with left ventricular ejection fraction <30% after primary percutaneous coronary intervention for ST-elevation myocardial infarction. The American Journal of Cardiology, 100, 793–7.
Hohnloser, S. H., & Gersh, B. J. (2003). Changing late prognosis of acute myocardial infarction: impact on management of ventricular arrhythmias in the era of reperfusion and the implantable cardioverter-defibrillator. Circulation, 107, 941–6.
Solomon, S. D., Zelenkofske, S., & McMurray, J. J. (2005). Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. The New England Journal of Medicine, 352, 2581–8.
Pouleur, C., Pouleur, A. C., Barkoudah, E., Uno, H., Skali, H., Finn, P. V., et al. (2010). Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure or both. Circulation, 122, 597–602.
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., et al. (2004). Prophylactic use of an implantable cardioverter defibrillator after acute myocardial infarction. The New England Journal of Medicine, 351, 2481–8.
Steinbeck, G., Andresen, D., Seidl, K., Brachmann, J., Hoffmann, E., Wojciechowski, D., et al. (2009). Defibrillator implantation early after myocardial infarction. The New England Journal of Medicine, 361(15), 1427–3.
Raviele, A., Bongiorni, M. G., Brignole, M., Cappato, R., Capucci, A., Gaita, F., et al. (2005). Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment: the BEtablocker STrategy plus ICD trial. Europace, 7, 327–37.
The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. (1997). A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventriculararrhythmias. The New England Journal of Medicine, 337, 1576–83.
Connolly, S. J., Gent, M., Roberts, R. S., et al. (2000). Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation, 101, 1297–302.
Kuck, K. H., Cappato, R., Siebels, J., & Ruppel, R. (2000). Randomized comparisonof antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation, 102, 748–54.
Zaman, S., Sivagangabalan, G., Narayan, A., Thiagalingam, A., Ross, D. L., & Kovoor, P. (2009). Outcomes of early risk stratification and targeted implantable cardioverter-defibrillator implantation after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Circulation, 120, 194–2009.
Hammill, S. C., Kremers, M. S., Stevenson, L. W., et al. (2008). Review of the Registry’s second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm, 5, 1359–63.
Fuster, V., Rydén, L. E., Cannom, D. S., et al. (2006). ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Journal of the American College of Cardiology, 48, 854–906.
Al-Khatib, S., Calkins, H., Benjamin, E., et al. (2010). Registry initiative (SAFARI) as a collaborative pan-stakeholder critical path registry model: a Cardiac Safety Research Consortium. American Heart Journal, 159, 17–24.
Calkins, H., Brugada, J., Packer, D. L., et al. (2007). HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Europace, 9, 335–79.
Shah, D. C., Haïssaguerre, M., Jaïs, P., et al. (2000). Electrophysiologically guided ablation of the pulmonary veins for the curative treatment of atrial fibrillation. Annali Medici, 32, 408–16.
Haïssaguerre, M., Shah, D. C., Jaïs, P., et al. (2000). Mapping-guided ablation of pulmonary veins to cure atrial fibrillation. The American Journal of Cardiology, 86, 9K–19.
Pappone, C., Augello, G., Sala, S., et al. (2006). A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. Journal of the American College of Cardiology, 48, 2340–7.
Stabile, G., Bertaglia, E., Senatore, G., et al. (2006). Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study). European Heart Journal, 27, 216–21.
Wazni, O. M., Marrouche, N. F., Martin, D. O., et al. (2005). Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA, 293, 2634–40.
Jaïs, P., Cauchemez, B., Macle, L., et al. (2008). Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation, 118, 2498–505.
Calkins, H., Reynolds, M. R., Spector, P., et al. (2009). Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviewed and meta-analyses. Circulation: Arrhythmia and Electrophysiology, 2, 349–61.
Krittayaphong, R., Raungrattanaamporn, O., Bhuripanyo, K., et al. (2003). A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. Journal of the Medical Association of Thailand, 86(Suppl 1), S8–16.
Oral, H., Pappone, C., Chugh, A., et al. (2006). Circumferential pulmonary-vein ablation for chronic atrial fibrillation. The New England Journal of Medicine, 354, 934–41.
Jaïs, P., Shah, D. C., Hocini, M., et al. (2000). Radiofrequency catheter ablation for atrial fibrillation. Journal of Cardiovascular Electrophysiology, 11, 758–61.
Nair, G. M., Nery, P. B., Diwakaramenon, S., et al. (2009). A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. Journal of Cardiovascular Electrophysiology, 20, 138–44.
Ablation versus anti-arrhythmic drug therapy for AF—pivotal trial (NCT00911508). ClinicalTrials.gov Web site. http://www.clinicaltrials.gov. Accessed 24 Sept 2009.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Estes, N.A.M., Homoud, M., Weinstock, J. et al. Interdisciplinary strategies for arrhythmia program development: measuring quality, performance, and outcomes. J Interv Card Electrophysiol 31, 91–99 (2011). https://doi.org/10.1007/s10840-011-9554-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-011-9554-4